GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mymetics Corp (OTCPK:MYMX) » Definitions » Cyclically Adjusted PB Ratio

Mymetics (Mymetics) Cyclically Adjusted PB Ratio : (As of May. 28, 2024)


View and export this data going back to 1995. Start your Free Trial

What is Mymetics Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Mymetics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Mymetics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mymetics Cyclically Adjusted PB Ratio Chart

Mymetics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mymetics Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mymetics's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Mymetics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mymetics's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mymetics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Mymetics's Cyclically Adjusted PB Ratio falls into.



Mymetics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Mymetics's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 is calculated as:

For example, Mymetics's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book=Book Value per Share/CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-531.018/106.5695*106.5695
=-531.018

Current CPI (Sep. 2023) = 106.5695.

Mymetics Quarterly Data

Book Value per Share CPI Adj_Book
201312 -248.770 101.036 -262.396
201403 -259.513 101.224 -273.217
201406 -255.439 101.517 -268.153
201409 -249.559 101.247 -262.679
201412 -244.278 100.704 -258.506
201503 -220.641 100.339 -234.342
201506 -232.750 100.464 -246.896
201509 -238.260 99.785 -254.459
201512 -235.910 99.386 -252.961
201603 -245.352 99.475 -262.850
201606 -254.253 100.088 -270.718
201609 -261.246 99.604 -279.515
201612 -269.331 99.380 -288.817
201703 -281.703 100.040 -300.090
201706 -301.666 100.285 -320.570
201709 -328.009 100.254 -348.674
201712 -334.099 100.213 -355.291
201803 -355.359 100.836 -375.566
201806 -345.338 101.435 -362.818
201809 -353.134 101.246 -371.704
201812 -352.239 100.906 -372.009
201903 -358.935 101.571 -376.600
201906 -366.237 102.044 -382.479
201909 -364.854 101.396 -383.471
201912 -374.552 101.063 -394.959
202003 -380.899 101.048 -401.714
202006 -395.832 100.743 -418.725
202009 -422.083 100.585 -447.197
202012 -443.363 100.241 -471.355
202103 -443.692 100.800 -469.089
202106 -457.776 101.352 -481.341
202109 -455.972 101.533 -478.593
202112 -447.024 101.776 -468.080
202203 -444.430 103.205 -458.918
202206 -435.930 104.783 -443.363
202209 -417.119 104.835 -424.021
202212 -452.634 104.666 -460.865
202303 -470.595 106.245 -472.034
202306 -531.090 106.576 -531.060
202309 -531.018 106.570 -531.018

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mymetics  (OTCPK:MYMX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Mymetics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Mymetics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mymetics (Mymetics) Business Description

Industry
Traded in Other Exchanges
N/A
Address
c/o Mymetics SA, Route de la Corniche 4, Biopole Center, Epalinges, CHE, CH-1066
Mymetics Corp is a vaccine company and is focused on the research and development of next-generation vaccines for infectious and life-disabling diseases. Its vaccine candidates in the pipeline include HIV-1/AIDS, malaria, and Covid-19, and intranasal influenza, RSV, Chikungunyaand HSV vaccine candidate programs.
Executives
Marcel B. Ruegg director C/O MYMETICS CORPORATION, ROUTE DE LA CORNICHE 4 1066, EPALINGES V8 NA
Kempers Ronald Hugo Gerard officer: President, CEO, CFO ES GRANDS CHAMPS 12, DULLY V8 1195
Christopher S Henney director 10505 ROSELLE STREET, SAN DIEGO CA 92121
Grant Pickering director, officer: President and CEO C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS CA 94070
Ulrich Burkhard director C/O MYMETICS CORPORATION, ROUTE DE LA CORNICHE 4 1066, EPALINGES V8 NA
Jacques Francois Martin officer: CEO 40 QUAI FULCHIRON, LYON I0 69005
Antonius Johannes Stegmann officer: CSO KONINGIN EMMAPLANTSOEN 6, RIJNSBURG P7 2231TZ
Ernest M Stern director 815 CONNECTICUT AVE, NW, SUITE 500, SEYFARTH SHAW LLP, WASHINGTON DC 20006
Thomas Staehelin director POSTFACH 2879, FROMER, SCHULTHEISS & STAEHELIN, BASEL V8 CH-4002
Sylvain Fleury officer: CSO CHEMIN DE VERDONNET 9, LAUSANNE V8 1010
Round Enterprises, Ltd. 10 percent owner C/O BACHMANN TRUST COMPANY LIMITED, FRANCES HOUSE, SIR WILLIAM PLACE, ST. PETER PORT X0 GY1 4EA
Mfc Bancorp Ltd 10 percent owner ROOM 2103 SHANGHAI MART TOWER, 2299 YAN AN ROAD WEST, CHANGNING DISTRICT, SHANGHAI F4 200336
Christian Rochet director, officer: CEO 14, RUE DE LA COLOMBIERE, NYON V8 1260
Robert Zimmer director, officer: vp corp development
Ernst Lubke director, officer: CFO 39, ROUTE D'ARZIER, ARZIER V8 CH-1273

Mymetics (Mymetics) Headlines